TickerFactsScreenerDevelopers

Arbutus Biopharma Corp (ABUS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$10.69M2012: -$12.95M2013: -$12.15M2014: -$33.43M2015: -$103.92M2016: -$491.64M2017: -$110.93M2018: -$89.78M2019: -$143.90M2020: -$57.81M2021: -$73.52M2022: -$65.46M2023: -$78.10M2024: -$76.32M2025: -$38.16M-$38.16M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$38.16M+50.0%
2024-$76.32M+2.3%
2023-$78.10M-19.3%
2022-$65.46M+11.0%
2021-$73.52M-27.2%
2020-$57.81M+59.8%
2019-$143.90M-60.3%
2018-$89.78M+19.1%
2017-$110.93M+77.4%
2016-$491.64M-373.1%
2015-$103.92M-210.8%
2014-$33.43M-175.1%
2013-$12.15M+6.1%
2012-$12.95M-21.1%
2011-$10.69M—